Financial News
AbbVie (NY: ABBV )
173.35
+1.03
(+0.60%)
Streaming Delayed Price
Updated: 11:43 AM EDT, Jul 22, 2024
Add to My Watchlist
Press Releases about AbbVie
![](https://mms.businesswire.com/media/20230426005263/en/1732938/5/square-logo-old-blue_2023.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230412163450_why-next-weeks-earnings-report-is-good-for-johnson.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230327084053_biontech-is-ripe-for-a-rebound-in-2023.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230322074035_these-3-dividend-growers-yield-more-than-the-10-ye.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230314095754_healthcare-stocks-with-at-least-30-years-of-divide.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230313090705_diversify-your-income-with-these-2-high-yielding-d.jpg)
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
![](https://www.marketbeat.com/logos/articles/small_20230306160941_the-stock-that-tripled-in-a-day.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230301141122_wall-street-sees-23-upside-in-revance-maker-of-bot.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230222074139_analyst-confidence-in-eli-lilly-boosted-by-product.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230220130828_johnson-johnson-taking-the-bull-by-the-horns.jpg)
Johnson & Johnson: Taking The Bull By The Horns?
February 21, 2023
Via MarketBeat
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
![](https://www.marketbeat.com/logos/articles/small_20230216194034_how-abbott-labs-abbvie-could-profit-on-seizure-dru.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230210133108_abbvie-has-a-mixed-outlook-after-mixed-earnings.jpg)
AbbVie Has a Mixed Outlook After Mixed Earnings
February 13, 2023
Via MarketBeat
![](https://www.marketbeat.com/logos/articles/small_stock-image_18303557_S.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_319147404_S.jpg)
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
Via MarketBeat
![](https://www.marketbeat.com/logos/articles/small_stock-image_439122574_S.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.marketbeat.com/logos/articles/small_stock-image_413908228_S.jpg)
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID
November 17, 2022
Exposures
COVID-19
![](https://www.marketbeat.com/logos/articles/small_stock-image_225227766_S.jpg)
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
![](https://www.marketbeat.com/logos/articles/small_stock-image_477117228_S.jpg)
![](https://pressreach.com/wp-content/uploads/2022/10/Abbvie-Stock.jpg)
Via PressReach
Topics
Economy
![](https://www.marketbeat.com/logos/articles/small_stock-image_344636530_S.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_524132478_S.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.